High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting.

Détails

ID Serval
serval:BIB_F82B67B9AE70
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
High-resolution molecular karyotyping in patients with developmental delay and/or multiple congenital anomalies in a clinical setting.
Périodique
Clinical Genetics
Auteur(s)
Wincent J., Anderlid B.M., Lagerberg M., Nordenskjöld M., Schoumans J.
ISSN
1399-0004 (Electronic)
ISSN-L
0009-9163
Statut éditorial
Publié
Date de publication
2011
Volume
79
Numéro
2
Pages
147-157
Langue
anglais
Notes
Publication types: Evaluation Studies ; Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish. PDF type: Short report.
Résumé
Microarray-based comparative genomic hybridization (array-CGH) enables genomewide investigation of copy-number changes at high resolution and has recently been implemented as a clinical diagnostic tool. In this study we evaluate the usefulness of high-resolution arrays as a diagnostic tool in our laboratory and investigate the diagnostic yield in the first 160 patients who were clinically referred for investigation of developmental delay (DD)/multiple congenital anomalies (MCA). During this period both 38K BAC-arrays and 244K oligonucleotide-arrays were used. Copy-number variations (CNVs) not previously reported as normal variants were detected in 22.5% of cases. In 13.1% the aberrations were considered causal to the phenotype and in 9.4% the clinical significance was uncertain. There was no difference in diagnostic yield between patients with mild, moderate or severe DD. Although the effective resolution of the 244K oligonucleotide-arrays was higher than the 38K BAC-array, the diagnostic yield of both platforms was approximately equal and no causal aberrations <300 kb were detected in this patient cohort. We experienced that increasing the resolution of a whole genome screen in the diagnostic setting has its drawback of detecting an increased number of CNVs with uncertain contribution to a phenotype. Based on our experiences, array-CGH is recommended as the first-step analysis in the genetic evaluation of patients with DD and/or MCA.
Mots-clé
Abnormalities, Multiple/diagnosis, Abnormalities, Multiple/genetics, Adolescent, Adult, Child, Child, Preschool, Developmental Disabilities/diagnosis, Developmental Disabilities/genetics, Female, Genetic Testing/methods, Humans, Infant, Infant, Newborn, Karyotyping/methods, Male, Middle Aged, Molecular Diagnostic Techniques, Oligonucleotide Array Sequence Analysis, Severity of Illness Index, Young Adult
Pubmed
Création de la notice
31/10/2013 17:31
Dernière modification de la notice
03/03/2018 22:51
Données d'usage